Status:
RECRUITING
Transcranial Direct Current Stimulation and Modulation of Affect and Pain
Lead Sponsor:
Trustees of Dartmouth College
Conditions:
We Are Not Studying a Disease or Condition
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
This double-blind randomized crossover study aims to examine the effects of left primary motor cortex (M1) tDCS on evoked thermal pain perception, pain-related decision making, and placebo effects by ...
Detailed Description
This study aims to examine the effects of M1 tDCS on induced experimental pain, pain-related decision making, and independently manipulate expectations based on the pain and monetary offered by others...
Eligibility Criteria
Inclusion
- ages 18-55
- Participants must be capable of performing experimental tasks (e.g., are able to read)
- Fluent or native speakers of English
Exclusion
- No self-reported current or history of depression, bipolar disorder, or other psychiatric diagnosis.
- No self-reported current seizure disorder (i.e., seizure within past 10 years)
- No history of stroke or other major neurological diagnosis.
- No self-reported current chronic pain, or acute pain within three months of the study period.
- No current migraine disorder (i.e., 15 headache days or more in 1 month).
- No use of central nervous system-effective medication or other medication for neurological/psychiatric treatment. No self-reported substance abuse within the last six months.
- No contraindication to MRI or tDCS (e.g., pregnancy, claustrophobia, pacemakers, ear/cochlear implants, shrapnel injuries, clips, or other ferromagnetic/electrical objects/devices, diagnosed brain abnormality such as tumor, or skin lesions on the scalp.).
- No contraindications for induced pain (e.g., no heart disease, high blood pressure, heart surgery, heart problems of any kind, severe asthma, respiratory problems of any kind, fibromyalgia, Raynaud's Syndrome or Disease, chronic pain, diabetes).
Key Trial Info
Start Date :
September 9 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06989749
Start Date
September 9 2023
End Date
September 1 2026
Last Update
May 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dartmouth College
Hanover, New Hampshire, United States, 03755